Ruifeng Yang

4PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 12, 2026
METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7/DNA2 axis and mitophagy regulation.

|Dec 06, 2023
Myeloid cells interact with a subset of thyrocytes to promote their migration and follicle formation through NF-κB.

Rui-Meng Yang, Shi-Yang Song, Feng-Yao Wu

|Mar 17, 2023
Taurodeoxycholic acid-YAP1 upregulates OTX1 in promoting gallbladder cancer malignancy through IFITM3-dependent AKT activation.

Ruifeng Yang, Linhua Yang, Manmei Long

|Jul 30, 2020
Long noncoding RNA PVT1 promotes tumor growth and predicts poor prognosis in patients with diffuse large B-cell lymphoma.

Ruifeng Yang, Tingting Shao, Manmei Long

Pageof 1

Frequent Collaborators

1 joint publications

Yan-Ting Shen

1 joint publications

Shuang-Xia Zhao

1 joint publications

Huai-Dong Song

1 joint publications

Ming Zhan